// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Six-month Outcomes from the Multicenter, Prospective Study with the Novel PASCAL Transcatheter Valve Repair System for Patients with Mitral Regurgitation in the CLASP Study

Sula Mazimba - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mitral valve regurgitation

N/A

Influence of Age on the Efficacy and Safety of Spironolactone in Heart Failure with Preserved Ejection Fraction

Orly Vardeny - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Heart failure with preserved ejection fraction

Spironolactone

Echocardiographic Characteristics of Heart Failure Patients with Severe Tricuspid Regurgitation

Chrystina M. Kiwan - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Tricuspid regurgitation

N/A

Residual Congestion on Discharge for Heart Failure Assessed by Impedance Technique Predicts 30-Day and One-Year Heart Failure Death. Results of IMPEDANCE-HF Extended Trial

Michael Kleiner Shochat - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary edema

N/A

Clinical Predictors of QRS Duration in Patients with LBBB: Data from the AdaptResponse Trial

Gerasimos Filippatos - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Prior and Incident Myocardial Infarction in HFpEF: A Pooled, Patient-Level Analysis of 3 Contemporary Clinical Trials with 8,916 Patients

Jonathan W. Cunningham - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial

Mona Fiuzat - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Withdrawal of Beta- Blockers and ACE Inhibitors after Left Ventricular Systolic Function Recovery in Patient with Dilated Cardiomyopathy Randomized Control Trial

Abeer Bakhsh - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

N/A

Temporal Association of Atrial Fibrillation with Device Based Heart Failure Status in Patients with CRT

John P. Boehmer - Heart Failure Society of America (HFSA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Surgical Repair of Bicuspid Aortopathy at Diameters <4.5 cm Is Common and Is Influenced by Clinical and Institutional Factors

Alexander P. Nissen - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Angiographic and Clinical Outcomes Following Revascularization with Radial Artery Bypass Grafts: Insights from the PREVENT-IV Trial

Oliver K. Jawitz - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Randomized Controlled Trial Evaluating the Impact of Active Chest Tube Clearance on Outcomes after Cardiac Surgery

Samuel St-Onge - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prognostic Impact of Tumor Microenvironment After Accelerated Radiation and Radical Surgery for Malignant Pleural Mesothelioma

Marc de Perrot - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Malignant pleural mesothelioma

N/A

Indirect Coronary Reimplantation Is Associated with Increased Operative Risk in Patients Undergoing a Bentall Procedure After Previous Cardiac Surgery

Amine Mazine - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal insufficiency

N/A

Prospective, Multi-Center, International Phase 2 Trial Evaluating Ultrasonic Energy for Pulmonary Artery Branch Sealing in VATS Lobectomy

Moishe Liberman - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Endobronchial Ultrasound-Guided Radiofrequency Ablation of Lung Tumors and Mediastinal Lymph Nodes: A Preclinical Study in Animal Lung Tumor and Mediastinal Adenopathy Models

Yamato Motooka - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

Nicotinamide

Contemporary

Outcomes of Aortic - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Infective endocarditis

N/A

Del Nido Cardioplegia Versus Blood Cardioplegia in Adult Aortic Root Surgery

Lenoir Marien - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pulmonary Artery Banding in AVSD

Paul Joseph Devlin - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Atrioventricular septal defect

N/A

Rationale, Design, and Cohort Characteristics of the Tetralogy of Fallot for Life (TOF LIFE) Study

Sara Hussain - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Tetralogy of fallot

N/A

Copyright © 2026. QuantiNova All rights reserved